Soft‐tissue sarcomas (STS) are rare tumors that account for 1% of all adult malignancies,
with over 100 different histologic subtypes occurring predominately in the trunk, extremity …

Desmoid tumors (DT) are rare, locally aggressive, fibroblastic soft-tissue tumors that are
characterized by infiltrative growth and can affect organs and adjacent structures, resulting …

Background Desmoid tumors are rare, locally aggressive, highly recurrent soft-tissue tumors
without approved treatments. Methods We conducted a phase 3, international, double-blind …

Highlights•This Clinical Practice Guideline provides key recommendations on the
management of soft tissue and visceral sarcomas.•Recommendations have been agreed …

The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis,
evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN …

Chest wall tumors are a relatively uncommon disease in clinical practice. Most of the
published studies about chest wall tumors are usually single-center retrospective studies …

Desmoid tumors (DTs) are rare soft tissue mesenchymal neoplasms that may be associated
with impairments, disfigurement, morbidity, and (rarely) mortality. DT disease course can be …

Desmoid tumor (DT) is a rare, soft tissue neoplasm associated with an unpredictable clinical
course. Although lacking metastatic potential, DT is often locally aggressive and invasive …

Desmoid tumors (DTs) are a rare disease of intermediate malignancy characterized
histologically by a locally aggressive, monoclonal, fibroblastic proliferation and clinically by …

This paper describes the standard of care for patients with non-rhabdomyosarcoma soft
tissue sarcomas (NRSTS) and the therapeutic recommendations developed by the …